GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN COOPER | — |
| KENNETH E RASKE | — |
| DAVID C RICH | — |
| BRUCE C VLADECK | — |
| SUSAN C WALTMAN | — |
| ELISABETH R WYNN | — |
Medicare/Medicaid MMM
Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (H.R.2124/S.1148) - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; Strengthening Medicare Advantage through Innovation and Transparency for Seniors (H.R.2570) - oppose; Medicare Inpatient Prospective Payment System FY 2016 proposed rule (CMS 1632-P) - detailed comment letter; legislation to improve the recovery audit contractor program (H.R.2156); Audit and Appeal Fairness, Integrity and Reforms in Medicare Act (AFIRM) - provided comments to the Senate Finance Committee; Ensuring Seniors Access to Local Pharmacies Act of 2015 (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Act (S.776) - support; CMS-4159-F2 - comments on daily dispensing fees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ALFREDO New | — |
| JONATHAN COOPER | — |
| KAREN SMOLER HELLER | — |
| TIM JOHNSON | — |
| LEE H PERLMAN | — |
| KENNETH E RASKE | — |
| DAVID C RICH | — |
| KATHLEEN SHURE | — |
| AISLING WARDE ZACCARELLI | — |
| ELISABETH R WYNN | — |
Pharmacy PHA
Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524 - comments on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN COOPER | — |
| LEE H PERLMAN | — |
| KENNETH E RASKE | — |
| DAVID C RICH | — |
| SHARA SIEGEL New | — |
| AISLING WARDE ZACCARELLI | — |
Insurance INS
Support House and Senate proposal for re-authorization of the Terrorism Risk Insurance Act (H.R.26).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN COOPER | — |
| KENNETH E RASKE | — |
| DAVID C RICH | — |
Budget/Appropriations BUD
House and Senate Budget Resolutions, provisions relating to Medicare reductions - oppose (H.Con.Res. 27, S.Con.Res.11)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN COOPER | — |
| KENNETH E RASKE | — |
| DAVID C RICH | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| GNYHA SERVICES, INC. | New York, NY, US |
| GNYHA VENTURES, INC. | New York, NY, US |
| INNOVATIX, LLC | New York, NY, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.